The Estimation of Prevalence, Incidence, and Residual Risk of Transfusion-Transmitted Human Hepatitis B Infection from Blood Donated at the Anhui Blood Center, China, from 2009 to 2011

被引:9
|
作者
Li, Wuping [1 ,2 ,3 ]
Gao, Zhan [2 ,3 ]
Yang, Chunhui [2 ,3 ]
Li, Jiahu [4 ]
Li, Ling [4 ]
Lv, Rong [4 ]
Liu, Zhong [2 ,3 ,4 ]
机构
[1] Chinese Acad Med Sci, Inst Pathogen Biol, MOH Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China
[2] Peking Union Med Coll, Beijing 100021, Peoples R China
[3] Chinese Acad Med Sci, Inst Blood Transfus, Beijing 100730, Peoples R China
[4] Anhui Blood Ctr, Hefei, Anhui, Peoples R China
来源
PLOS ONE | 2013年 / 8卷 / 09期
关键词
HUMAN-IMMUNODEFICIENCY-VIRUS; C VIRUS; VIRAL-INFECTIONS; DONORS; IMPACT;
D O I
10.1371/journal.pone.0073472
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: The high prevalence of hepatitis B virus (HBV) among the Chinese population poses a threat to blood safety; however, few studies have examined epidemiological data regarding HBV infection of Chinese blood donors. The present study investigated the demographic characteristics of blood donors at the Anhui blood center in China, the prevalence, incidence, and residual risk (RR) associated with hepatitis B surface antigen (HBsAg) expression in terms of transfusion transmitted HBV (TTHBV) infections. Methods: The demographic characteristics and HBV status of people who donated blood at the Anhui blood center between 2009 and 2011 were retrospectively analyzed. The incidence of HBV was estimated through HBsAg yield approach. The window period model was then used to estimate the RR of TTHBV infection. Results: The typical donor at the Anhui blood center was a first-time volunteer, aged less than 25 years, unmarried, of Han ethnicity, and with an education below high school level. The prevalence of HBV infection among repeat donors, first-time donors, and all donors was 28.9, 127.2 and 82.1 per 100,000, respectively. The incidence estimate was 333.9 per 105 person-years. Using an infectious window period of 59 days, the RR for HBV was estimated to be 1 in 1853 between 2009 and 2011. Conclusions: The incidence and RR of HBV in Chinese blood donors are much higher than those of donors in developed countries. This is because sensitive ELISAs and nucleic acid tests are not available in China. Further work is needed to improve both the safety and availability of blood products in China.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Prevalence, incidence and residual risk of transfusion-transmitted hepatitis B virus infection in Italy from 2009 to 2018
    Velati, Claudio
    Romano, Luisa
    Pati, Ilaria
    Marano, Giuseppe
    Piccinini, Vanessa
    Catalano, Liviana
    Pupella, Simonetta
    Vaglio, Stefania
    Veropalumbo, Eva
    Masiello, Francesca
    Pisani, Giulio
    Grazzini, Giuliano
    Zanetti, Alessandro
    Liumbruno, Giancarlo M.
    BLOOD TRANSFUSION, 2019, 17 (06) : 409 - 417
  • [2] The residual risk of transfusion-transmitted HIV infection in a public Brazilian blood center.
    Pinto, Ana Cristina S.
    Valente, Vanderleia B.
    Ubiali, Eugenia Maria A.
    Angulo, Ivan L.
    Covas, Dimas T.
    BLOOD, 2006, 108 (11) : 115B - 115B
  • [3] Residual risk of transfusion-transmitted hepatitis B virus (HBV) infection caused by blood components derived from donors with occult HBV infection in Japan
    Taira, Rikizo
    Satake, Masahiro
    Momose, Shun'ya
    Hino, Satoru
    Suzuki, Yoshiharu
    Murokawa, Hiroyuki
    Uchida, Shigeharu
    Tadokoro, Kenji
    TRANSFUSION, 2013, 53 (07) : 1393 - 1404
  • [4] The residual risk of transfusion-transmitted cytomegalovirus infection associated with leucodepleted blood components
    Seed, C. R.
    Wong, J.
    Polizzotto, M. N.
    Faddy, H.
    Keller, A. J.
    Pink, J.
    VOX SANGUINIS, 2015, 109 (01) : 11 - 17
  • [5] CURRENT INCIDENCE AND ESTIMATED RESIDUAL RISK OF TRANSFUSION-TRANSMITTED HUMAN IMMUNODEFICIENCY VIRUS INFECTION IN QINGDAO, CHINA
    Feng, Q.
    Zhou, B.
    VOX SANGUINIS, 2011, 101 : 94 - 94
  • [6] Prevalence, incidence, and residual risks for transfusion-transmitted human immunodeficiency virus Types 1 and 2 infection among Chinese blood donors
    Wang, Jingxing
    Liu, Jing
    Yao, Fuzhu
    Wen, Guoxin
    Li, Julin
    Huang, Yi
    Lu, Yunlai
    Wen, Xiuqiong
    Wright, David
    Yu, Qilu
    Guo, Nan
    Ness, Paul
    Shan, Hua
    TRANSFUSION, 2013, 53 (06) : 1240 - 1249
  • [7] Transfusion-transmitted virus infection in China: Prevalence in blood donors and in patients with liver diseases
    He, C
    Nomura, F
    Yukimasa, N
    Itoga, S
    Yamada-Osaki, M
    Sumazaki, R
    Nakai, T
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1999, 14 (09) : 899 - 903
  • [8] Residual risk of transfusion-transmitted infection with human immunodeficiency virus, hepatitis C virus, and hepatitis B virus in Korea from 2000 through 2010
    Kim, Moon Jung
    Park, Quehn
    Min, Hyuk Ki
    Kim, Hyun Ok
    BMC INFECTIOUS DISEASES, 2012, 12
  • [9] Residual risk of transfusion-transmitted infection with human immunodeficiency virus, hepatitis C virus, and hepatitis B virus in Korea from 2000 through 2010
    Moon Jung Kim
    Quehn Park
    Hyuk Ki Min
    Hyun Ok Kim
    BMC Infectious Diseases, 12
  • [10] Blood donor screening: how to decrease the risk of transfusion-transmitted hepatitis B virus?
    Niederhauser, Christoph
    Taleghani, Behrouz Mansouri
    Gmziani, Mauro
    Stolz, Martin
    Tinguely, Caroline
    Schneider, Philippe
    SWISS MEDICAL WEEKLY, 2008, 138 (9-10) : 134 - 141